SUPRIYA.NS

Supriya Lifescience Limited [SUPRIYA.NS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

SUPRIYA.NS Stock Summary

Top 10 Correlated ETFs

SUPRIYA.NS


Top 10 Correlated Stocks

SUPRIYA.NS


In the News

SUPRIYA.NS Financial details

Company Rating
Buy
Market Cap
27.43B
Income
1.2B
Revenue
5.54B
Book val./share
-
Cash/share
-
Dividend
0.6
Dividend %
0.2%
Employees
392
Optionable
No
Shortable
Yes
Earnings
29 May 2024
P/E
24.23
Forward P/E
17.9
PEG
-11.72
P/S
4.67
P/B
3.22
P/C
-
P/FCF
-
Quick Ratio
3.14
Current Ratio
6.26
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
14.96
EPS next Y
18.6
EPS next Q
-
EPS this Y
-40.83%
EPS next Y
24.33%
EPS next 5Y
53.07%
EPS last 5Y
-6.27%
Revenue last 5Y
10.65%
Revenue Q/Q
-0.01%
EPS Q/Q
24.58%
-
-
-
-
SMA20
-5.67%
SMA50
8.82%
SMA100
33.2%
Inst Own
-
Inst Trans
-
ROA
12%
ROE
28%
ROC
0.18%
Gross Margin
60%
Oper. Margin
27%
Profit Margin
19%
Payout
-
Shs Outstand
80.48M
Shs Float
21.41M
-
-
-
-
Target Price
-
52W Range
170.15-394.0
52W High
-15.49%
52W Low
+95.85%
RSI
50
Rel Volume
0.28
Avg Volume
649.24K
Volume
181.94K
Perf Week
1.74%
Perf Month
-7.41%
Perf Quarter
23.34%
Perf Half Y
19.44%
-
-
-
-
Beta
0.264
-
-
Volatility
5.21%, 14.58%
Prev Close
-1.93%
Price
332.95
Change
-0.91%

SUPRIYA.NS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric History 2019-03-312020-03-312021-03-312022-03-31 2023-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
108.75121.99150.8464.5357.27
Net income per share
15.4328.7348.3818.8611.16
Operating cash flow per share
19.0545.4331.296.068.22
Free cash flow per share
16.3335.8312.4-1.38-5.24
Cash per share
4.8529.2435.0127.9520.38
Book value per share
36.7158.4105.2776.586.91
Tangible book value per share
35.9357.15104.0976.3186.77
Share holders equity per share
36.7158.4105.2776.586.91
Interest debt per share
40.1635.7629.863.763.17
Market cap
9.99B9.99B9.99B39.7B15.35B
Enterprise value
10.89B10.81B10.4B38.32B14.72B
P/E ratio
25.3313.68.0826.1517.09
Price to sales ratio
3.593.22.597.643.33
POCF ratio
20.528.612.4981.3623.2
PFCF ratio
23.9310.9131.51-357.58-36.37
P/B Ratio
10.656.693.716.452.19
PTB ratio
10.656.693.716.452.19
EV to sales
3.923.472.77.383.19
Enterprise value over EBITDA
15.59.935.8417.3710.64
EV to operating cash flow
22.389.3213.0178.5222.25
EV to free cash flow
26.111.8132.81-345.12-34.88
Earnings yield
0.040.070.120.040.06
Free cash flow yield
0.040.090.030-0.03
Debt to equity
0.980.570.270.040.03
Debt to assets
0.370.250.160.040.03
Net debt to EBITDA
1.290.760.23-0.63-0.45
Current ratio
0.991.271.824.994.85
Interest coverage
5.9814.7240.7872.6937.99
Income quality
0.851.210.480.240.54
Dividend Yield
00.02000
Payout ratio
00.240.030.030.05
Sales general and administrative to revenue
0.030.030.030.030.04
Research and developement to revenue
00000
Intangibles to total assets
0.010.010.0100
Capex to operating cash flow
-0.14-0.21-0.6-1.23-1.64
Capex to revenue
-0.02-0.08-0.13-0.12-0.24
Capex to depreciation
-1.28-3.85-7.22-5.92-9.18
Stock based compensation to revenue
00000
Graham number
112.9194.3338.51180.19147.76
ROIC
0.220.330.360.230.12
Return on tangible assets
0.160.220.280.210.11
Graham Net
-25.11-12.692.5835.6920.5
Working capital
-19.82M426.05M1.2B3.98B3.69B
Tangible asset value
918.04M1.46B2.66B6.14B6.98B
Net current asset value
-263.36M107.56M895.17M3.78B3.44B
Invested capital
0.980.570.270.040.03
Average receivables
448.98M818.13M754.37M1.29B1.33B
Average payables
429.4M467.6M502.07M499.97M566M
Average inventory
312.15M400.95M609.7M823.96M1.04B
Days sales outstanding
117.9786.4772.97126.7167.48
Days payables outstanding
92.82110.77123.277.75129.66
Days of inventory on hand
64.64110.92175.01146.57233.7
Receivables turnover
3.094.2252.885.41
Payables turnover
3.933.32.964.692.82
Inventory turnover
5.653.292.092.491.56
ROE
0.420.490.460.250.13
Capex per share
-2.72-9.6-18.88-7.44-13.47

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
13.0417.6916.417.4217.4
Net income per share
1.184.753.542.973.7
Operating cash flow per share
0.730.750.980.990.98
Free cash flow per share
0.730.750.980.990.98
Cash per share
23.5220.3919.5814.960
Book value per share
80.8886.9586.9193.660
Tangible book value per share
086.82093.50
Share holders equity per share
80.8886.9586.9193.660
Interest debt per share
0.132.880.10.770.06
Market cap
18.95B15.34B19.95B22.59B25.33B
Enterprise value
20.84B14.72B21.52B21.61B25.33B
P/E ratio
49.810.0317.4923.6421.26
Price to sales ratio
18.0210.7815.1116.1218.08
POCF ratio
321.11255.13252.18283.71319.85
PFCF ratio
321.11255.13252.18283.71319.85
P/B Ratio
2.912.192.8530
PTB ratio
2.912.192.8530
EV to sales
19.8210.3416.315.4218.08
Enterprise value over EBITDA
125.525.8145.463.1456.86
EV to operating cash flow
353.24244.7272.1271.37319.85
EV to free cash flow
353.24244.7272.1271.37319.85
Earnings yield
0.010.020.010.010.01
Free cash flow yield
00000
Debt to equity
00.0300.010
Debt to assets
00.0300.010
Net debt to EBITDA
11.42-1.13.32-2.870
Current ratio
04.8506.260
Interest coverage
13.4775.9549.6865.7382.17
Income quality
0.620.160.280.330.27
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00.05000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
46.3496.4383.2379.110
ROIC
0.020.050.040.030
Return on tangible assets
00.0500.030
Graham Net
23.5220.5119.5817.890
Working capital
1.9B3.69B1.58B3.45B0
Tangible asset value
06.98B07.52B0
Net current asset value
1.9B3.44B1.58B3.21B0
Invested capital
00.0300.010
Average receivables
403.5M426.07M426.07M426.96M426.96M
Average payables
269.13M321.14M321.14M275.99M275.99M
Average inventory
531.51M578.85M578.85M494.13M494.13M
Days sales outstanding
053.91054.860
Days payables outstanding
0121.54080.590
Days of inventory on hand
0219.070144.30
Receivables turnover
01.6701.640
Payables turnover
00.7401.120
Inventory turnover
00.4100.620
ROE
0.010.050.040.030
Capex per share
00000

SUPRIYA.NS Frequently Asked Questions

What is Supriya Lifescience Limited stock symbol ?

Supriya Lifescience Limited is a IN stock and trading under the symbol SUPRIYA.NS

What is Supriya Lifescience Limited stock quote today ?

Supriya Lifescience Limited stock price is $332.95 today.

Is Supriya Lifescience Limited stock public?

Yes, Supriya Lifescience Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Similar Market Cap